Characterisation of T-cell responses in patients with liver injury following treatment with the BACE inhibitor atabecestat (2020)
Attributed to:
Definition of the naturally-processed drug-peptide adducts that can act as functional T-cell antigens
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Journal Article/Review
Volume: submitted for publication
Parent Publication: Hepatology